2023
DOI: 10.1039/d3qo01312j
|View full text |Cite
|
Sign up to set email alerts
|

Reductive thiolation and oxidative dehydroaromatization of cyclohexanones with primary amines and sodium sulfinates to access o-sulfanylanilines

Hui Wu,
Lin Zhao,
Wenting Wang
et al.

Abstract: HI-promoted cascade reactions of cyclohexanones with primary amines and sodium sulfinates are described, which provides an unprecedented method to access o-sulfanylanilines using cyclohexanones as an aryl source and sodium sulfinates...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 47 publications
(21 reference statements)
0
2
0
Order By: Relevance
“…Another widely used strategy to synthesize sulfones is the coupling reaction of sulfinates. 22–29 All these protocols are based on organic sulfur-containing reagents, which are often difficult to prepare and therefore of limited availability. For this reason, new methodologies that avoid the use of unstable and toxic reagents, and harsh reaction conditions are in high demand.…”
mentioning
confidence: 99%
“…Another widely used strategy to synthesize sulfones is the coupling reaction of sulfinates. 22–29 All these protocols are based on organic sulfur-containing reagents, which are often difficult to prepare and therefore of limited availability. For this reason, new methodologies that avoid the use of unstable and toxic reagents, and harsh reaction conditions are in high demand.…”
mentioning
confidence: 99%
“…Primary sulfonamides are prevalent in bioactive molecules, especially in pharmaceuticals, and have become a privileged fragment in drug discovery . Late-stage functionalization of sulfonamides mainly relies on N -terminal substitutions . Direct derivatization of sulfonamide-based drugs will represent a facile and powerful strategy for accelerating drug innovation.…”
mentioning
confidence: 99%